Squamous cell carcinoma of the colon - a case report
Language English Country Czech Republic Media print
Document type Case Reports, Journal Article
PubMed
33108883
DOI
10.14735/amko2020380
PII: 124441
Knihovny.cz E-resources
- Keywords
- colorectal, squamous cell carcinoma, systemic treatment,
- MeSH
- Cisplatin administration & dosage MeSH
- Deoxycytidine administration & dosage analogs & derivatives MeSH
- Gemcitabine MeSH
- Humans MeSH
- Colonic Neoplasms drug therapy pathology surgery MeSH
- Antineoplastic Combined Chemotherapy Protocols therapeutic use MeSH
- Aged MeSH
- Carcinoma, Squamous Cell drug therapy pathology surgery MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- Cisplatin MeSH
- Deoxycytidine MeSH
- Gemcitabine MeSH
BACKGROUND: Primary squamous cell carcinomas (SCC) of the colon are extremely rare and occur predominantly in the fifth decade of life, with a slight prevalence in men. The most common anatomical sites are the rectum and the proximal colon. Clinical signs and common dia-gnostic methods cannot clearly distinguish SCC from adenocarcinoma. METHODS: In this case report, we present a case of a 68-year-old patient with SCC of the cecum and colon ascendens, who was treated with resection and systemic gemcitabine- and cisplatin-based chemotherapy. RESULTS: A 68-year-old patient underwent right-sided hemicolectomy for cecal and colon ascendens tumor, histologically poorly differentiated epidermoid carcinoma, grade 3 with an initial stage of pT4aN1aM0. Due to local recurrence at the resection site with suspected infiltration of straight and oblique abdominal muscles, he was treated with systemic gemcitabine and cisplatin based chemotherapy with partial remission. Subsequently, the postchemotherapeutic residual tumor was radically resected, achieving complete remission of the disease, which persists for 10 months after the surgery. CONCLUSION: The case emphasizes the need for a multidisciplinary treatment approach of this rare disease. Early surgery plays a key role. Although the standard chemotherapy regimen is not well defined, the use of a combination of cisplatin and gemcitabine resulted in partial remission in our patient, which in turn allowed a radical resection of the relapse and subsequently achieved complete remission of the disease.
References provided by Crossref.org